Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study
Journal
Ophthalmology and therapy
Journal Volume
13
Journal Issue
1
Date Issued
2024-01
Author(s)
Donati, Simone
Yang, Chang-Hao
Xu, Xun
Mura, Marco
Giocanti-Aurégan, Audrey
Hoerauf, Hans
Allmeier, Helmut
Machewitz, Tobias
Johnson, Kristian T
Santoro, Elina
Abstract
AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) in the treatment of diabetic macular edema (DME) or macular edema secondary to retinal vein occlusion in routine clinical practice. The 24-month outcomes in the DME cohort from across 11 participating countries are reported here.
Subjects
Anti-vascular endothelial growth factor; Diabetes; Diabetic macular edema; Diabetic retinopathy; Intravitreal aflibercept; Observational study; Real-world evidence; Retinal disease
Type
journal article